Ravascor adult stem cells: Interim Phase I/II data

Interim data from an open-label, U.S. Phase I/II trial in 18 patients who received a bone marrow transplant (BMT) using Revascor-expanded hematopoietic stem and progenitor cells from cord blood showed...